PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease

doi:10.12998/wjcc.v6.i10.355

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6885)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

440

WORD

249

HTML

3309

Figures (1-3)

193

Tables (1-4)

376

Sum=4567

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

915

Download

1403

Sum=2318

Sep 26, 2018 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Cases. Sep 26, 2018; 6(10): 355-364
Published online Sep 26, 2018. doi: 10.12998/wjcc.v6.i10.355

Full Size Figure Download Figure

Figure 1 Dynamic distribution of quality control samples throughout the Ultra-high performance liquid chromatography-tandem mass spectrometry analysis. Colored bars indicate the quality control samples that are projected onto the first principal component with a range from -2 SD to +2 SD. QC: Quality control; SD: Standard deviation.

Citation: Luo JJ, Cao HX, Yang RX, Zhang RN, Pan Q. PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease. World J Clin Cases 2018; 6(10): 355-364
URL: https://www.wjgnet.com/2307-8960/full/v6/i10/355.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i10.355